fibrinogen has been researched along with Arterial Occlusive Diseases in 171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 91 (53.22) | 18.7374 |
| 1990's | 35 (20.47) | 18.2507 |
| 2000's | 30 (17.54) | 29.6817 |
| 2010's | 13 (7.60) | 24.3611 |
| 2020's | 2 (1.17) | 2.80 |
| Authors | Studies |
|---|---|
| Doelare, SAN; Ebben, HP; Ergin, K; Hoksbergen, AWJ; Jongkind, V; Lely, RJ; Oukrich, S; Wiersema, AM; Yeung, KK | 1 |
| Benner, P; Betoule, A; Foucher, S; Gasperini, G; Martinet, C; Muller, P; Renard, A | 1 |
| Clark, RAF; Fenner, J; McClain, SA; Sasson, A; Singer, AJ; Tonnesen, MG | 1 |
| Chiles, PG; Emmerich, J; Gamst, AC; Gugiu, GB; Le Gal, G; Marsh, JJ; Meyer, G; Moore, RE; Morris, TA; Planquette, B; Sanchez, O; Wolfson, T | 1 |
| Morinobu, A; Onishi, A; Waki, D | 1 |
| Cragg, AH; Ehrenwald, E; Gits, CC; Skeik, N | 1 |
| Ariëns, R; Bridge, KI; Philippou, H | 1 |
| DeRose, G; Dubois, L; Forbes, TL; Istl, A; Kribs, S; Lee, K; Mujoomdar, A; Power, AH; Wiseman, D | 1 |
| Baumgartner, I; Diehm, N; Dörffler-Melly, J; Husmann, M; Kalka, C; Silvestro, A | 1 |
| Arnold, E; González-Manchón, C; Green, D; Jayo, A; Lord, ST | 1 |
| Galanakis, D; Henschen, A; Miesbach, W; Neerman-Arbez, M; Scharrer, I; Spitzer, S | 1 |
| Raabe, RD | 1 |
| Akkerman, JW; Cate, HT; Hauer, AD; Hildebrand, RB; Hoekstra, M; Korporaal, SJ; Kuiper, J; Meurs, I; Praticò, D; Van Berkel, TJ; Van Eck, M | 1 |
| Marchewka, A; Mika, A; Mika, P; Nizankowski, R; Wilk, B | 1 |
| Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhao, JG; Zhu, YQ | 1 |
| Comerota, AJ; Davis, JP; Deng, C; Fineberg, D; Hanna, K; Marder, VJ; Shlansky-Goldberg, RD | 1 |
| Brzoska, T; Buczko, W; Chlopicki, S; Fedorowicz, A; Grochal, E; Kramkowski, K; Leszczynska, A; Mann, B; Mogielnicki, A; Motterlini, R; Urano, T | 1 |
| Ahmadi, R; Exner, M; Haumer, M; Minar, E; Mlekusch, W; Rumpold, H; Schillinger, M; Wagner, O | 1 |
| Blinov, M; Harrington, DJ; Harrington, P; Kapustin, S; Malefora, A; Mitchell, M; Papayan, L; Savidge, GF; Schmeleva, V | 1 |
| Anthony, JP; Borsa, JJ; Burkart, DJ; Thurlo, SR | 1 |
| Kobayashi, S; Maesato, K; Moriya, H; Negishi, K; Ohtake, T | 1 |
| INGRAM, GI | 1 |
| Connor, JM; Cooke, A; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
| Biro, F; Kuegler, C; Michler, E; Rudofsky, G; Strubel, G | 1 |
| Hull, JE; Hull, MK; Urso, JA | 1 |
| Bastounis, E; Mirilas, P; Papalambros, E; Sigala, F; Travlou, A | 1 |
| Amundsen, SR; Aune, S; Dregelid, E; Eide, GE; Jenssen, GL; Jonung, T; Laxdal, E; Pedersen, G; Wirsching, J | 1 |
| Markland, FS; Swenson, S | 1 |
| He, Y; Li, XY; Ni, B; Wang, J | 1 |
| Criqui, MH; Ferrucci, L; Green, D; Greenland, P; Guralnik, JM; Liu, K; McDermott, MM; Pearce, WH; Ridker, PM; Rifai, N; Schneider, JR; Taylor, LM; Tian, L; Vonesh, E; Zheng, J | 1 |
| Chin-Dusting, J; Dart, AM; Jackson, S; Kling, D; Kulkarni, S; Woollard, KJ | 1 |
| Kobayashi, S; Maesato, K; Moriya, H; Ohtake, T; Oka, M; Okamoto, K | 1 |
| Dörner, T; Hoppe, B; Kiesewetter, H; Salama, A; Tolou, F | 1 |
| Borozanov, V; Bosevski, M; Kostoska, S; Tosev, S | 1 |
| Berger, W; Christe, M; Duckert, F; Fritschi, J; Lämmle, B; Marbet, GA; Tran, TH | 1 |
| Bell, WR; Reiner, AP | 1 |
| Forbes, CD; Lorimer, AR; Lowe, GD; McArdle, BM; Prentice, CR; Stromberg, P | 1 |
| Abruzzese, G; Avellone, G; Fazio, M; Mandalà, V; Riolo, FP | 1 |
| Caimi, G; Capobianco, D; Catania, A; Francavilla, G; Frazzetta, F; Romano, A; Sarno, A | 1 |
| Lambert, H; Laprevote-Heully, MC; Larcan, A | 1 |
| Dormandy, JA | 1 |
| Ernst, E | 4 |
| Biland, L; Christe, M; Delley, A; Duckert, F; Marbet, GA | 1 |
| Buchbinder, N; Charuzi, Y; Fishbein, MC; Ganz, W; Kass, R; Maddahi, J; Marcus, H; Miyamoto, A; Mondkar, A; O'Connor, L; Shell, W; Swan, HJ | 1 |
| Kester, RC; Learoyd, P; McCollum, CN; Pepper, M; Rajah, SM | 1 |
| Aburahma, AF; Osborne, L | 1 |
| Battistini, G; Pretolani, E; Salvi, P; Zoli, I | 1 |
| Artale, F; Cramarossa, L; Francisci, A; Giunti, P; Perego, MA; Sergio, G | 1 |
| Artale, F; Francisci, A; Giunti, P; Perego, MA; Sergio, G | 1 |
| Auriemma, L; Di Martino, G; Florio, A; Iannucci, F; Matarazzo, A; Rosati, V | 1 |
| Jung, F; Kieswetter, H; Körber, N; Reim, M | 1 |
| Bandyk, DF; Berni, GA; Strandness, DE; Thiele, BL; Zierler, RE | 1 |
| Artale, F; Cramarossa, L; Di Palma, A; Perego, MA; Sergio, G | 1 |
| Böhme, H; Everts, B | 1 |
| Latorre, J; Marinello, J; Olba, L; Rosendo, A; Rutllant, ML; Sala Planell, E | 1 |
| Abbott, WM; Brewster, DC; Darling, RC; McCabe, CJ; Moncure, AC; Reidy, NC; Reilly, MK | 1 |
| Schmid-Schönbein, H | 1 |
| Keil, G; Konrad-Graf, S; Staiger, J | 1 |
| Clagett, GP; Hufnagel, H; Russo, M | 1 |
| Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A | 1 |
| Koenig, W | 1 |
| Binaghi, F; Cannas, F; Caredda, E; Fronteddu, PF; Garau, P; Pitzus, F; Uras, A | 1 |
| Bonino, F; Fabris, F; Macchione, C; Molaschi, M; Neirotti, M; Poli, L; Ponzetto, M | 1 |
| Cesnik, H; Lechner, H; Lechner, P; Walzl, B; Walzl, M | 1 |
| Ernst, E; Resch, KL | 1 |
| Jay, RJ | 1 |
| Baele, G; Clement, DL; De Buyzere, M; Duprez, D; Philippé, J | 1 |
| Arosio, E; Bosello, O; Ferrari, M; Guidi, GC; Lucchese, L; Prior, M | 1 |
| Burgmann, H; Ehringer, H; Graninger, W; Hollenstein, U; Koppensteiner, R; Maca, T; Thalhammer, F; Zedwitz-Liebenstein, K | 1 |
| Love, JG; Lowe, GD; Murray, GD; Pollock, JG; Rumley, A; Woodburn, KR | 1 |
| Love, J; Lowe, GD; Pollock, JG; Rumley, A; Woodburn, KR | 1 |
| Kao, SC; Shieh, WB; Tsai, CJ; Wu, MS | 1 |
| Adam, D; Bradbury, A; Brittenden, J; Garrioch, M; Gillies, T; Ruckley, CV | 1 |
| Beer, JH; Kauhanen, P; Lassila, R | 1 |
| Elger, B; Laux, V; Schwarz, M | 1 |
| Jäger, K; Labs, KH; Marbet, GA; Tsakiris, DA; Tschopl, M | 1 |
| Kauffman, JW; Kucuk, O; Kwaan, HC; Levin, M; Lis, LJ; Rooney, MW; Sakurai, S | 1 |
| Chen, L; Gustafsson, D; Mattsson, C; Mehta, JL; Nichols, WW; Saldeen, TG | 1 |
| Love, JG; Lowe, GD; Murray, GD; Rumley, A; Woodburn, KR | 1 |
| Ernst, E; Koenig, W | 1 |
| Cisar, LA; Kostis, JB; Philipp, CS; Saidi, P | 1 |
| Brentegani, C; Cordiano, C; Dorucci, V; Dusi, R; Guidi, G; Lippi, G; Ruzzenente, O; Veraldi, GF | 1 |
| Balbarini, A; Barchielli, A; Berchiolli, R; Dell' Omo, G; Ferrari, M; Mariani, M; Melillo, E; Pedrinelli, R | 1 |
| Fowkes, FG; Lee, AJ; Lowe, GD; Mowbray, PI; Price, JF; Rumley, A | 1 |
| Artmann, GM; Bauer, U; Dikta, G; Landsmann, B; Li, AL; Schanowski-Bouvier, P; Shi, YD | 1 |
| Clement, D; De Buyzere, M; Delanghe, J; Duprez, D; Langlois, M | 1 |
| Hodkinson, G; Hultquist, M; Kandarpa, K; Ouriel, K; Schuerr, DM; Wallin, B | 1 |
| Lowe, GD; Rumley, A | 1 |
| Grant, PJ; Lane, DA | 1 |
| Jäger, KA; Labs, KH; Marbet, GA; Tsakiris, DA; Tschöpl, M; Wolf, F | 1 |
| Applegate, WB; Chesney, CM; Davis, KB; Elam, MB; Garg, R; Herd, JA; Hunninghake, D; Kennedy, JW | 1 |
| Aissa-Benhaddad, A; Baskürt, O; Bouchahda, C; Brun, JF; Granat, MC; Mercier, J; Sagnes, C | 1 |
| Böhrer, H; Graf, BM; Gries, A; Herr, A; Martin, E; Seelos, R; Weis, S | 1 |
| Budinsky, AC; Sinzinger, H; Wolfram, RM | 1 |
| Assmann, G; Heinrich, J; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A | 1 |
| Ahmadi, R; Exner, M; Haumer, M; Minar, E; Mlekusch, W; Schillinger, M; Schlerka, G | 1 |
| Jahn, P; Jung, N; Nielebock, E; Richter, WO; Tachezy, H | 1 |
| Arepally, A; Geschwind, JF; Hofmann, LV; Kim, HS; Kirkwood, S; Oechsle, D; Perler, B | 1 |
| Coppola, A; Coppola, L; Giunta, L; Giunta, R; Grassia, A; Guastafierro, S; Luongo, C; Mascolo, L; Sammartino, A; Tirelli, A | 1 |
| Flavell, DM; Hawe, E; Humphries, SE; Jamshidi, Y; MacCallum, PK; Meade, TW | 1 |
| Likar, IN; Likar, LJ; Robinson, RW | 1 |
| Dean, RH; Yao, JS | 1 |
| Auel, H; Bopp, J; Büchner, U; Martin, M | 1 |
| Schetz, J; Vermylen, J; Verstraete, M | 1 |
| Aiach, M; Fiessinger, JN; Juillet, Y; Michaud, A; Vayssairat, M | 1 |
| Barnes, RW | 1 |
| Ehrly, AM; Saeger-Lorenz, K | 1 |
| Fujimaki, M; Furukawa, K; Ishimaru, S; Konishi, M; Takahashi, M | 1 |
| Chabrun, B; Conard, J; Horellou, MH; Milochevitch, R; Prestat, J; Samama, M | 1 |
| Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C | 1 |
| Bliss, BP; Harris, PL; Harvey, DR | 1 |
| Heidrich, H | 1 |
| Agnusdei, D; Di Perri, T; Forconi, S; Guerrini, M; Laghi Pasini, F | 1 |
| Klose, HJ; Malotta, H; Schmid-Schönbein, H; Volger, E; Weiss, J | 1 |
| Dintenfass, L; Ibels, LS | 1 |
| Siegel, ME; Wagner, HN | 1 |
| Wolf, GK | 1 |
| Havlik, E; Höfer, R; Sabeti, M; Weidinger, P | 1 |
| Albert, JP; Bruhn, HD; Petermann, W | 1 |
| Kakkar, VV; Lane, DA; Rampling, MW; Robbins, A | 1 |
| Straub, PW | 1 |
| Andersen, CA; Collins, GJ; McDonald, PT; Rich, NM; Scialla, S | 1 |
| Dormandy, JA; Goyle, KB | 1 |
| Auel, H; Martin, M | 1 |
| Ehrly, AM; Köhler, HJ | 1 |
| Mulcare, RJ; Phillips, LL; Royster, TS | 1 |
| Gurewich, V; Hoffmann, KD; Lipinska, I; Lipinski, B | 1 |
| Ehrly, AM | 3 |
| Crawford, GP; Gibbs, NM; Michalopoulos, N | 1 |
| Chesebro, JH; Fuster, V; Grill, DE; Heras, M; Mruk, JS; Webster, MW | 1 |
| Cooper, J; Howarth, DJ; Meade, TW; Miller, GJ; Stirling, Y | 1 |
| Barrett, JS; Cuca, GC; Gardell, SJ; Holahan, MA; Li, P; Lynch, JJ; Mellott, MJ; Stabilito, II; Wang, S | 1 |
| Nakamura, F; Sonoki, H; Sugimoto, T; Tomaru, T; Tsukamoto, M; Uchida, Y | 1 |
| Andersen, E; Bülow, J; Holstein, P; Jørgensen, B; Jørgensen, M; Nielsen, JD; Tønnesen, KH | 1 |
| Kobayashi, N; Maekawa, T; Matsumoto, M; Uchiyama, T | 1 |
| Ehringer, H; Jung, M; Koppensteiner, R; Minar, E | 1 |
| Ciuffetti, G; Lombardini, R; Mannarino, E; Mercuri, M; Palazzetti, D; Pasqualini, L; Scarponi, AM; Siepi, D | 1 |
| Kirk, CR; Qureshi, SA | 1 |
| Donaldson, MC; Hadjimichael, J; Matthews, ET; Rickles, FR | 1 |
| Graor, RA; Hotchkiss, A; Lucas, FV; Robison, AK; Sobel, BE; Tiefenbrunn, AJ | 1 |
| Schafer, AI | 1 |
| Baxter, K; Greenhalgh, R; Powell, J; Wiseman, S | 1 |
| Lechner, H; Niederkorn, K; Suzuki, H | 1 |
| Earnshaw, JJ; Hopkinson, BR; Makin, GS; Westby, JC | 1 |
| Anderle, K; Anger, G; Hartl, D; Philapitsch, A; Tiso, E | 1 |
| Formato, A; Molino, C; Mozzillo, N; Ottaviano, A; Quarto, G | 1 |
| Althoff, P; Breddin, HK; Kirchmaier, CM; Krzywanek, HJ; Rosak, C; Schepping, M; Schöffling, K; Uberla, K; Weichert, W; Ziemen, M | 1 |
| Dormandy, JA; Flute, PT; Hynd, JW; Mahir, MS | 1 |
| Artale, F; Danese, C; Giunti, P; Perego, MA; Sergio, G | 1 |
| Drury, J; Lieberman, P; Lowe, GD; Pollock, J; Saniabadi, A; Turner, A | 1 |
| Frank, I; Hänsgen, K; Klare, M; Podhaisky, H; Preuss, EG; Sternitzky, R | 1 |
| Aiach, M; Fiessinger, JN; Gaux, JC; Housset, E; Leclerc, M; Pernes, JM; Roncato, M; Vitoux, JF | 1 |
| Bernardo, B; Bertone, L; Bracale, G; De Caterina, M; Scalise, E; Selvetella, L | 1 |
| Davies, JW; Forsberg, K; Liljedahl, SO; Mårtensson, O; Reizenstein, P | 1 |
| Patman, RD; Persson, AV; Thompson, JE | 1 |
| Asbeck, F; Lechler, E; Martin, M; van de Loo, J | 1 |
| Lippmann, HI | 1 |
| Gillespie, JA | 1 |
| Latallo, ZS; Lopaciuk, S | 1 |
| Mandel, EE; Minn, SK | 1 |
| Chakrabarti, R | 1 |
| Scrobohaci, ML; Stăncioiu, N | 1 |
| Conard, J; Samama, M | 1 |
| Duckert, F; Fridrich, R; Hofer, B; Neidhart, P | 1 |
| Dudczak, R; Ehringer, H; Lechner, K | 1 |
22 review(s) available for fibrinogen and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Clot properties and cardiovascular disease.
Topics: Arterial Occlusive Diseases; Blood Coagulation; Cardiovascular Agents; Cardiovascular Diseases; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Porosity; Venous Thrombosis | 2014 |
Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
Topics: Aged; Angina Pectoris; Antigens, CD; Antigens, Surface; Arterial Occlusive Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Lectins, C-Type; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; NK Cell Lectin-Like Receptor Subfamily B; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors; Scotland; Smoking | 2003 |
The fibrinolytic system in man.
Topics: alpha 1-Antitrypsin; alpha-2-Antiplasmin; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Arterial Occlusive Diseases; Arteriosclerosis; Complement C1 Inactivator Proteins; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Kidney Diseases; Liver Diseases; Myocardial Infarction; Neoplasms; Plasminogen; Pulmonary Embolism; Thrombophlebitis | 1984 |
[Clinical use of thrombolytic agents].
Topics: Arterial Occlusive Diseases; Blood Coagulation Tests; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Humans; Streptokinase; Thromboembolism; Urokinase-Type Plasminogen Activator | 1983 |
[The influence of hemorrheology on the practice of clinical medicine].
Topics: Adult; Age Factors; Aged; Arterial Occlusive Diseases; Blood Physiological Phenomena; Blood Viscosity; Diabetic Angiopathies; Erythrocytes; Female; Fibrinogen; Hematocrit; Hemodilution; Hemodynamics; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Models, Biological; Myocardial Infarction; Oxygen Consumption; Phlebitis; Plasmapheresis; Preoperative Care; Raynaud Disease; Rheology | 1983 |
[Correlation between various hemorheological factors in peripheral obstructive arterial diseases].
Topics: Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans; Male; Middle Aged; Plethysmography, Impedance | 1980 |
[Hyperfibrinogenemia and cardiovascular risk--epiphenomenon or causal relationship?].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Risk Factors; Survival Rate | 1995 |
Fibrinogen: its emerging role as a cardiovascular risk factor.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Smoking | 1994 |
Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
Topics: Acute-Phase Reaction; Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Infections; Inflammation; Male; Middle Aged; Prospective Studies; Risk Factors | 1993 |
Digital ischemia and gangrene due to red blood cell aggregation induced by acquired dysfibrinogenemia.
Topics: Arterial Occlusive Diseases; Erythrocyte Aggregation; Fibrinogen; Fingers; Gangrene; Humans; Male; Middle Aged | 1997 |
Fibrinogen and cardiovascular risk.
Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Reference Values; Risk Factors | 1997 |
Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.
Topics: Animals; Arterial Occlusive Diseases; Biomarkers; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Thrombosis | 1999 |
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
Topics: 3' Untranslated Regions; Arterial Occlusive Diseases; Blood Coagulation Factors; Factor V; Factor VII; Factor XIII; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Hemostasis; Humans; Hyperhomocysteinemia; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Point Mutation; Polymorphism, Genetic; Prothrombin; Receptors, Cell Surface; Risk Factors; Sequence Deletion; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2000 |
[Hemorheological aspects of leuko-platelet activation in atheromatous diseases: clinical applications].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Blood Platelets; Blood Viscosity; Cytokines; Endothelium, Vascular; Feedback; Fibrinogen; Free Radicals; Hemorheology; Humans; Inflammation; Ischemia; Leg; Leukocytes; Nitric Oxide; Risk Factors; Thrombophilia; Thrombosis | 2000 |
Assessment of peripheral arterial vascular disease with radionuclide techniques.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Fibrinogen; Humans; Immunoglobulins; Indium Radioisotopes; Lipoproteins; Monocytes; Muscles; Nuclear Medicine; Organotechnetium Compounds; Peptides; Peripheral Vascular Diseases; Porphyrins; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed | 2001 |
Glycosaminoglycans and arterial disease.
Topics: Animals; Arterial Occlusive Diseases; Arteries; Blood Coagulation; Catecholamines; Cell Division; Cells, Cultured; Cholesterol; Drug Stability; Enzyme Activation; Fibrinogen; Glycosaminoglycans; Hormones; Humans; Mast Cells; Protein Binding; Radiation Effects; Structure-Activity Relationship; Wound Healing | 1975 |
Hemodynamic measurements in peripheral vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Electromagnetic Phenomena; Fibrinogen; Fingers; Hand; Hemodynamics; Humans; Ischemia; Middle Aged; Plethysmography, Impedance; Radionuclide Imaging; Rheology; Thrombophlebitis; Ultrasonography; Vascular Diseases | 1976 |
Noninvasive diagnostic techniques in peripheral vascular disease.
Topics: Arterial Occlusive Diseases; Auscultation; Blood Flow Velocity; Blood Pressure Determination; Doppler Effect; Equipment and Supplies, Hospital; Fibrinogen; Health Workforce; Humans; Laboratories; Ophthalmodynamometry; Physical Exertion; Plethysmography; Radioisotopes; Radionuclide Imaging; Rheology; Ultrasonics; Ultrasonography; Vascular Diseases | 1979 |
Radioactive tracers in peripheral vascular disease.
Topics: Amputation, Surgical; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Arteriovenous Fistula; Fibrinogen; Humans; Intermittent Claudication; Iodine Radioisotopes; Leg; Leg Ulcer; Osteitis Deformans; Radioisotopes; Radionuclide Imaging; Regional Blood Flow; Serum Albumin, Radio-Iodinated; Sodium Radioisotopes; Streptokinase; Technetium; Thrombophlebitis; Vascular Diseases; Xenon Radioisotopes | 1976 |
Non-coronary thrombolysis.
Topics: Arterial Occlusive Diseases; Combined Modality Therapy; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Recurrence; Thrombin Time; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1990 |
The hypercoagulable states.
Topics: Antithrombin III Deficiency; Arterial Occlusive Diseases; Biocompatible Materials; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Viscosity; Contraceptives, Oral; Diabetes Complications; Factor XII Deficiency; Female; Fibrinogen; Fibrinolysis; Glycoproteins; Hemoglobinuria, Paroxysmal; Homocystinuria; Humans; Hyperlipidemias; Lupus Coagulation Inhibitor; Myeloproliferative Disorders; Neoplasms; Nephrotic Syndrome; Pregnancy; Pregnancy Complications, Hematologic; Protein C; Protein S; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombocytosis; Thromboembolism; Vasculitis; Venous Insufficiency | 1985 |
Advances in the treatment of peripheral vascular disease.
Topics: Amputation, Surgical; Angiography; Aorta; Aortic Aneurysm; Arterial Occlusive Diseases; Cerebrovascular Disorders; Femoral Artery; Fibrinogen; Humans; Hypertension, Renal; Iliac Artery; Iodine Radioisotopes; Phlebography; Popliteal Artery; Sympathectomy; Thrombophlebitis; Vascular Diseases | 1972 |
20 trial(s) available for fibrinogen and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Ankle; Arterial Occlusive Diseases; Brachial Artery; C-Reactive Protein; Female; Femoral Artery; Fibrinogen; Humans; Inflammation Mediators; Intermittent Claudication; Ischemia; Leukocyte Count; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prospective Studies; Regional Blood Flow; Time Factors; Treatment Outcome; Ultrasonography; Vasodilation | 2008 |
The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
Topics: Aged; Analysis of Variance; Arterial Occlusive Diseases; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Exercise Test; Exercise Therapy; Exercise Tolerance; Female; Fibrinogen; Hematocrit; Humans; Intermittent Claudication; Lipids; Male; Middle Aged; Poland; Recovery of Function; Time Factors; Treatment Outcome; Triglycerides; Walking | 2011 |
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
Topics: Aged; Analysis of Variance; Angioplasty; Arterial Occlusive Diseases; Aspirin; Batroxobin; China; Constriction, Pathologic; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Magnetic Resonance Angiography; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2011 |
Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; alpha-Macroglobulins; Arterial Occlusive Diseases; Biomarkers; Brazil; Catheterization, Peripheral; Dose-Response Relationship, Drug; Europe; Female; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Graft Occlusion, Vascular; Hemorrhage; Humans; Infusions, Intra-Arterial; Lower Extremity; Male; Middle Aged; Radiography; South Africa; Thrombolytic Therapy; Time Factors; Treatment Outcome; United States; Young Adult | 2012 |
LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis.
Topics: Adult; Aged; Arterial Occlusive Diseases; Atherosclerosis; Biomarkers; Blood Component Removal; C-Reactive Protein; Coronary Stenosis; Female; Fibrinogen; Hemoperfusion; Humans; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Statistics, Nonparametric; Treatment Outcome | 2006 |
Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Coagulation; Blood Viscosity; Double-Blind Method; Erythrocyte Deformability; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Vascular Diseases; Photoplethysmography; Phthalic Acids; Platelet Aggregation Inhibitors | 1994 |
[Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cerebrovascular Disorders; Chemical Precipitation; Cholesterol; Coronary Disease; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Rheology; Triglycerides | 1993 |
Lipoprotein(a) and general risk factors in patients with angiographically assessed peripheral arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Body Constitution; Body Mass Index; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Radiography; Regression Analysis; Risk Factors; Smoking | 1995 |
Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease.
Topics: Adult; Antioxidants; Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemodynamics; Humans; Hypolipidemic Agents; Ischemia; Leg; Male; Middle Aged; Niacin; Warfarin | 1998 |
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
Topics: Aged; Arterial Occlusive Diseases; Biomarkers; Blood Pressure; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires; United Kingdom | 1999 |
Hemorheology and walking of peripheral arterial occlusive diseases patients during treatment with Ginkgo biloba extract.
Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Diabetic Angiopathies; Double-Blind Method; Drugs, Chinese Herbal; Erythrocyte Deformability; Female; Fibrinogen; Ginkgo biloba; Humans; Male; Middle Aged; Plants, Medicinal; Walking | 1998 |
Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
Topics: Aged; Angiography; Arterial Occlusive Diseases; Double-Blind Method; Enzyme Precursors; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Leg; Male; Prospective Studies; Recombinant Proteins; Safety; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator | 1999 |
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).
Topics: Aged; Anticoagulants; Antioxidants; Arterial Occlusive Diseases; Ascorbic Acid; beta Carotene; Blood Coagulation; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Humans; Male; Niacin; Vitamin E; von Willebrand Factor; Warfarin | 2000 |
Etomidate and thiopental inhibit platelet function in patients undergoing infrainguinal vascular surgery.
Topics: Aged; Anesthetics, Intravenous; Arterial Occlusive Diseases; Bleeding Time; Double-Blind Method; Etomidate; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Count; Protein Binding; Thiopental; Vascular Surgical Procedures | 2001 |
Fibrinogen adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience.
Topics: Adsorption; Aged; Arterial Occlusive Diseases; Blood Component Removal; Diabetic Foot; Female; Fibrinogen; Humans; Male; Middle Aged; Treatment Outcome | 2001 |
Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease.
Topics: 2,3-Diphosphoglycerate; Aged; Arterial Occlusive Diseases; Blood Transfusion, Autologous; Blood Viscosity; Erythrocyte Deformability; Female; Fibrinogen; Hemoglobins; Hemorheology; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxygen; Oxygen Consumption; Ozone | 2001 |
Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Apolipoprotein C-III; Apolipoproteins C; Arterial Occlusive Diseases; Base Sequence; Bezafibrate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Hypolipidemic Agents; Male; Middle Aged; Molecular Sequence Data; Peripheral Vascular Diseases; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Reference Values; Sensitivity and Specificity; Treatment Outcome | 2002 |
[Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases].
Topics: Ancrod; Arterial Occlusive Diseases; Blood Viscosity; Clinical Trials as Topic; Dextrans; Drug Therapy, Combination; Erythrocyte Aggregation; Fibrinogen; Humans; Oxygen; Partial Pressure | 1977 |
Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
Topics: Ancrod; Arterial Occlusive Diseases; Blood Viscosity; Clinical Trials as Topic; Depression, Chemical; Drug Evaluation; Endopeptidases; Female; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Injections, Subcutaneous; Male; Nicotinyl Alcohol; Pain; Phenprocoumon | 1976 |
The effect of anticoagulants on postoperative fibrinogen metabolism. Secondary anaemias, XVI.
Topics: Adult; Age Factors; Aged; Arterial Occlusive Diseases; Dicumarol; Female; Femoral Fractures; Fibrin; Fibrinogen; Half-Life; Heparin; Humans; Iodine Radioisotopes; Male; Middle Aged; Postoperative Care; Tibial Fractures; Time Factors | 1973 |
129 other study(ies) available for fibrinogen and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience.
Topics: Arterial Occlusive Diseases; Clinical Decision-Making; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Prospective Studies; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2023 |
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
Topics: Arterial Occlusive Diseases; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Decision Support Techniques; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Host-Pathogen Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Organ Dysfunction Scores; Pandemics; Platelet Count; Pneumonia, Viral; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Retrospective Studies; SARS-CoV-2; Thromboembolism; Venous Thrombosis | 2020 |
Blood vessel occlusion with erythrocyte aggregates causes burn injury progression-microvasculature dilation as a possible therapy.
Topics: Animals; Apoptosis; Arterial Occlusive Diseases; Burns; Disease Progression; Erythrocyte Aggregation; Fibrinogen; Humans; Inflammation; Ischemia; Microvessels; Necrosis; Peptides; Skin; Vasodilator Agents | 2018 |
Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Fibrinogen; France; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pulmonary Artery; Pulmonary Embolism | 2018 |
Large vessel vasculopathy in a patient with systemic lupus erythematosus: a case report.
Topics: Adult; Arterial Occlusive Diseases; Complement C3; Female; Fibrinogen; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Temporal Arteries; Tibial Arteries; Tunica Intima | 2019 |
Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Drug Monitoring; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lower Extremity; Male; Middle Aged; Minnesota; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Young Adult | 2013 |
Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Topics: Arterial Occlusive Diseases; Biomarkers; Catheterization, Peripheral; Down-Regulation; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Punctures; Retrospective Studies; Risk Assessment; Risk Factors; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2015 |
Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
Topics: Arterial Occlusive Diseases; Blood Coagulation Disorders, Inherited; Blood Coagulation Tests; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Testing; Hand Injuries; Hemorrhage; Heterozygote; Humans; Menorrhagia; Middle Aged; Molecular Weight; Mutation; Pedigree; Phenotype; Postpartum Hemorrhage; Thrombosis | 2009 |
Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects.
Topics: Abortion, Spontaneous; Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Amino Acid Substitution; Arterial Occlusive Diseases; Blood Coagulation Tests; Child; DNA Mutational Analysis; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Mutation, Missense; Point Mutation; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Hematologic; Protein Structure, Quaternary; Protein Subunits; Purpura; Sequence Deletion; Structure-Activity Relationship; Thrombosis; Young Adult | 2010 |
Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Combined Modality Therapy; Down-Regulation; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Middle Aged; Peripheral Vascular Diseases; Radiography; Retrospective Studies; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonic Therapy; Vascular Patency; Venous Thrombosis; Washington; Young Adult | 2010 |
Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Bone Marrow Transplantation; Chlorides; Cholesterol, Dietary; Cholesterol, HDL; Disease Models, Animal; Ferric Compounds; Fibrinogen; Mice; Mice, Knockout; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Scavenger Receptors, Class B; Thrombocytopenia; Thrombosis; Time Factors; Up-Regulation | 2011 |
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Gas Analysis; Blood Platelets; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Green Fluorescent Proteins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Organometallic Compounds; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Solubility; Thrombosis; Time Factors; Venous Thrombosis; Water | 2012 |
Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Biomarkers; C-Reactive Protein; Carotid Arteries; Cohort Studies; Female; Femoral Artery; Fibrinogen; Humans; Iliac Artery; Inflammation; Male; Middle Aged; Multivariate Analysis; Popliteal Artery; Prospective Studies; Serum Amyloid A Protein; Stents | 2002 |
Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.
Topics: Adult; Arterial Occlusive Diseases; DNA Mutational Analysis; DNA Primers; Factor V; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Prothrombin; Thromboembolism; Venous Thrombosis | 2003 |
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Disease-Free Survival; Drug Therapy, Combination; Eptifibatide; Female; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hematocrit; Hemoglobins; Hemorrhage; Humans; Iliac Artery; Iliac Vein; Lower Extremity; Male; Middle Aged; Missouri; Peptides; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Prospective Studies; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2003 |
LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Component Removal; Extremities; Female; Fibrinogen; Humans; Insulin-Like Growth Factor I; Ischemia; Lipoproteins, LDL; Male; Middle Aged; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2003 |
Plasma fibrinogen concentration in occlusive arterial disease.
Topics: Arterial Occlusive Diseases; Fibrin; Fibrinogen; Humans; Peripheral Vascular Diseases; Vascular Diseases | 1952 |
Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Treatment Outcome | 2004 |
Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
Topics: Abciximab; Analysis of Variance; Antibodies, Monoclonal; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Peripheral Vascular Diseases; Recombinant Proteins; Retrospective Studies; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2004 |
P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Blood Platelets; Cohort Studies; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; P-Selectin; Platelet Factor 4; Prospective Studies; Thrombocytopenia; Thromboembolism; Vascular Diseases; Venous Thrombosis | 2004 |
Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Biomarkers; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Graft Occlusion, Vascular; Hemostasis; Homocysteine; Humans; Knee; Limb Salvage; Male; Middle Aged; Multivariate Analysis; Norway; Popliteal Artery; Prospective Studies; Reoperation; Risk Factors; Statistics as Topic; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures | 2004 |
Snake venom fibrin(ogen)olytic enzymes.
Topics: Amino Acid Sequence; Amino Acids; Animals; Arterial Occlusive Diseases; Fibrinogen; Humans; Metalloendopeptidases; Metalloproteases; Models, Molecular; Molecular Sequence Data; Sequence Homology; Serine Endopeptidases; Snake Venoms; Snakes; Substrate Specificity | 2005 |
[Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; China; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Regression Analysis | 2005 |
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Body Mass Index; C-Reactive Protein; Cohort Studies; Comorbidity; Disability Evaluation; Exercise Test; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation Mediators; Male; Physical Fitness; Prognosis; Prospective Studies; Risk Factors; Serum Amyloid A Protein; Statistics as Topic | 2005 |
Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion.
Topics: Aged; Arterial Occlusive Diseases; Cell Adhesion; Female; Fibrinogen; Humans; Leukocytes; Male; Middle Aged; Neutrophils; P-Selectin; Peripheral Vascular Diseases | 2006 |
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Humans; Integrin alpha2; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Serine Endopeptidases; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2006 |
Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
Topics: Arterial Occlusive Diseases; Biomarkers; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate | 2006 |
Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Topics: Adult; Age Factors; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Thrombin Time | 1984 |
Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia.
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Arterial Occlusive Diseases; Blood Viscosity; Child; Female; Fibrinogen; Hematocrit; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Plasminogen Activators; Risk | 1982 |
[Hemocoagulative and fibrinolytic parameters in chronic obliterative vascular disease of the lower extremities].
Topics: Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation Tests; Fibrinogen; Humans; Leg; Middle Aged; Serum Globulins | 1980 |
[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle Aged; Propanolamines; Rheology; Suloctidil | 1983 |
[Therapeutic lowering of fibrinogen levels].
Topics: Ancrod; Arterial Occlusive Diseases; Batroxobin; Blood Viscosity; Fibrinogen; Humans; Peptide Hydrolases | 1983 |
Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.
Topics: alpha-2-Antiplasmin; Antigens; Antithrombin III; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Factor VIII; Fibrinogen; Hemostasis; Humans; Male; Myocardial Infarction; von Willebrand Factor | 1984 |
Intracoronary thrombolysis in evolving myocardial infarction.
Topics: Adult; Animals; Arterial Occlusive Diseases; Coronary Vessels; Creatine Kinase; Dogs; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Nitroglycerin; Plasminogen; Serum Globulins; Streptokinase; Time Factors | 1981 |
Arterial graft maturation: the duration of thrombotic activity in Dacron aortobifemoral grafts measured by platelet and fibrinogen kinetics.
Topics: Aged; Aorta; Arterial Occlusive Diseases; Blood Platelets; Blood Vessel Prosthesis; Female; Femoral Artery; Fibrinogen; Humans; Kinetics; Male; Middle Aged; Polyethylene Terephthalates; Thrombosis; Time Factors | 1981 |
Value and limitations of the noninvasive laboratory: experience with over 5,000 patients.
Topics: Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Constriction, Pathologic; Evaluation Studies as Topic; Eye; Fibrinogen; Humans; Laboratories; Leg; Plethysmography; Thrombophlebitis; Ultrasonography; Vascular Diseases; West Virginia | 1983 |
[Blood filterability in peripheral obstructive arterial disease].
Topics: Aged; Arterial Occlusive Diseases; Blood; Erythrocytes; Fibrinogen; Humans; Microcirculation; Middle Aged; Risk; Ultrafiltration | 1983 |
[Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocyte Aggregation; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Leg; Male; Middle Aged; Ultrafiltration | 1983 |
[Influence of age factors on the rheological properties of blood in healthy subjects and those with vascular disease].
Topics: Adult; Age Factors; Aged; Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Rheology; Ultrafiltration | 1983 |
[Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies].
Topics: Adult; Aged; Antithrombin III; Arterial Occlusive Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Thrombocytosis | 1983 |
Rheologic findings in patients with acute central retinal artery occlusion.
Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocyte Aggregation; Erythrocytes, Abnormal; Fibrinogen; Hematocrit; Humans; Regional Blood Flow; Retinal Artery; Retinal Diseases; Risk | 1983 |
Streptokinase treatment of acute arterial occlusion.
Topics: Aged; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Streptokinase; Time Factors | 1983 |
Hemodilution combined with defibrinogenation.
Topics: Adult; Ancrod; Arterial Occlusive Diseases; Batroxobin; Blood Viscosity; Fibrinogen; Hematocrit; Hemodilution; Humans; Male; Peptide Hydrolases | 1981 |
[Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
Topics: Adult; Aged; Ancrod; Arterial Occlusive Diseases; Blood Coagulation; Blood Viscosity; Chronic Disease; Drug Evaluation; Female; Fibrinogen; Humans; Male; Middle Aged | 1982 |
Deep venous thrombophlebitis following aortoiliac reconstructive surgery.
Topics: Adult; Aged; Aorta; Aortic Aneurysm; Arterial Occlusive Diseases; False Positive Reactions; Female; Fibrinogen; Humans; Iliac Artery; Iodine Radioisotopes; Male; Middle Aged; Phlebography; Postoperative Complications; Prospective Studies; Thrombophlebitis; Ultrasonography | 1982 |
[What is a microcirculatory disorder in chronic degenerative vascular disease? (author's transl)].
Topics: Arterial Occlusive Diseases; Fibrinogen; Hemodilution; Humans; Microcirculation; Snake Venoms; Vascular Diseases; Vasodilator Agents | 1981 |
Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
Topics: Adult; Aged; Ancrod; Arterial Occlusive Diseases; Female; Fibrinogen; Humans; Male; Middle Aged | 1981 |
Platelet changes after placement of aortic prostheses in dogs. II. Impaired surface-induced arterial thrombosis.
Topics: Animals; Aorta; Arterial Occlusive Diseases; Arteries; Aspirin; Blood Coagulation; Blood Platelets; Dogs; Female; Fibrinogen; Heparin; Leukocyte Count; Male; Partial Thromboplastin Time; Platelet Count; Prostheses and Implants; Prothrombin Time; Thrombosis; Time Factors | 1981 |
[Blood viscosimetric factors in cardiovascular pathology].
Topics: Angina Pectoris; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Diabetic Angiopathies; Fibrinogen; Hematocrit; Humans; Leg; Myocardial Infarction; Vascular Diseases | 1980 |
Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population.
Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Italy; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Prevalence; Risk Factors; Smoking; Surveys and Questionnaires | 1994 |
Fibrinogen and viscosity: risk factors for cardiovascular events.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Ischemia; Risk Factors | 1994 |
Routine measurement of fibrinogen concentration. Fibrinogen may be just a marker.
Topics: Arterial Occlusive Diseases; Biomarkers; Fibrinogen; Humans; Risk Factors | 1993 |
Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Physical Exertion | 1993 |
Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease.
Topics: Angiogenesis Inducing Agents; Arterial Occlusive Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Laminin; Male; Middle Aged; Peripheral Vascular Diseases; Proteins; Ribonuclease, Pancreatic | 1996 |
Clinical, biochemical, and rheologic factors affecting the outcome of infrainguinal bypass grafting.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Blood Viscosity; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemoglobins; Humans; Leg; Male; Middle Aged; Multivariate Analysis; Platelet Count; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures; Veins; von Willebrand Factor | 1996 |
Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
Topics: Age Factors; Aged; Angiography; Arterial Occlusive Diseases; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Reference Values; Rheology | 1995 |
Adult minimal change disease presenting with bilateral pulmonary artery thromboses--a reversible complication.
Topics: Administration, Oral; Adult; Anticoagulants; Antithrombin III; Arterial Occlusive Diseases; Fibrinogen; Humans; Male; Nephrosis, Lipoid; Prednisolone; Pulmonary Artery; Remission Induction | 1996 |
Changes in platelet count, coagulation and fibrinogen associated with elective repair of asymptomatic abdominal aortic aneurysm and aortic reconstruction for occlusive disease.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Blood Coagulation; Elective Surgical Procedures; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Count; Postoperative Period | 1997 |
Defective interaction between von Willebrand factor and platelet glycoprotein Ib--a familial study of peripheral arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood Cell Count; Blood Platelets; Cholesterol; Female; Fibrinogen; Fibrinolysis; Finland; Humans; Male; Middle Aged; Nuclear Family; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Reference Values; Ristocetin; Triglycerides; von Willebrand Factor | 1997 |
Magnetic resonance imaging studies on the effect of the fibrinogen-lowering agent ancrod on cerebral lesions in two rat models of acute stroke.
Topics: Acute Disease; Ancrod; Animals; Arterial Occlusive Diseases; Brain; Cerebral Arteries; Cerebral Infarction; Cerebrovascular Disorders; Fibrinogen; Fibrinolytic Agents; Magnetic Resonance Imaging; Male; Photochemistry; Rats; Rats, Inbred SHR | 1997 |
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Topics: Angioplasty, Balloon; Antithrombin III; Arterial Occlusive Diseases; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Diabetes Mellitus; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Metabolic Clearance Rate; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Prospective Studies; Prothrombin; Recurrence; Risk; Risk Factors; Smoking; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Treatment Failure; Ultrasonography, Doppler, Color; von Willebrand Factor | 1997 |
Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery.
Topics: Administration, Oral; Animals; Antithrombins; Arterial Occlusive Diseases; Azetidines; Benzylamines; Coronary Thrombosis; Dogs; Electric Stimulation; Fibrinogen; Fibrinolytic Agents; Glycine; Microscopy, Electron, Scanning; Partial Thromboplastin Time; Thrombin | 1998 |
Influence of graft material on blood rheology and plasma biochemistry following insertion of an infrainguinal bypass graft.
Topics: Aged; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Blood Viscosity; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Graft Survival; Humans; Male; Middle Aged; Polytetrafluoroethylene; Vascular Patency | 1998 |
Usefulness of lipids, lipoprotein(a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery.
Topics: Angioplasty, Balloon; Aorta; Arterial Occlusive Diseases; Carotid Arteries; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endarterectomy; Fibrinogen; Humans; Lipids; Lipoprotein(a); Postoperative Complications; Retinal Vein Occlusion; Risk Factors; Vascular Diseases | 1998 |
Fibrinogen and mortality in chronic critical limb ischaemia.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinogen; Humans; Ischemia; Italy; Leg; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis | 1999 |
Haptoglobin polymorphism and peripheral arterial occlusive disease.
Topics: Aged; Alleles; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Electrophoresis, Starch Gel; Exercise Test; Female; Fibrinogen; Gene Frequency; Haptoglobins; Humans; Male; Nephelometry and Turbidimetry; Phenotype; Polymorphism, Genetic; Triglycerides | 1999 |
Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Angioplasty; Arterial Occlusive Diseases; Blood Platelets; CD40 Ligand; Cell Adhesion Molecules; Cytokines; Endothelium, Vascular; Female; Fibrinogen; Growth Inhibitors; Humans; Male; Membrane Glycoproteins; Middle Aged; Mitral Valve Stenosis; Oncostatin M; Peptides; Platelet Activation; Platelet Count; Solubility | 2000 |
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Retrospective Studies; Severity of Illness Index | 2001 |
Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; C-Reactive Protein; Cohort Studies; Constriction, Pathologic; Female; Femoral Artery; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Popliteal Artery; Postoperative Complications; Predictive Value of Tests; Recurrence; Retrospective Studies; Time Factors; Vascular Patency | 2001 |
Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Body Weight; Catheterization, Peripheral; Child; Child, Preschool; Fibrinogen; Graft Occlusion, Vascular; Hematocrit; Humans; Infant; Middle Aged; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2002 |
[Treatment of iliac artery stenosis with low dose streptokinase (author's transl)].
Topics: Adult; Arterial Occlusive Diseases; Blood Pressure; Female; Fibrinogen; Fibrinolysin; Humans; Iliac Artery; Male; Middle Aged; Streptokinase; Time Factors | 1977 |
Biochemical changes noted during intermittent administration of streptokinase.
Topics: Antibodies; Antigen-Antibody Complex; Arterial Occlusive Diseases; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Plasminogen; Streptokinase; Thrombophlebitis | 1978 |
[Biological changes during the local administration of small doses of urokinase].
Topics: Arterial Occlusive Diseases; Endopeptidases; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Plasminogen; Urokinase-Type Plasminogen Activator | 1978 |
[Studies on blood coagulation systems during defibrinogenation therapy with batroxobin (Bothrops atrox venom) (author's transl)].
Topics: Arterial Occlusive Diseases; Batroxobin; Blood Coagulation; Crotalid Venoms; Fibrinogen; Humans; Peptide Hydrolases | 1979 |
[Haemorrhagic complications using streptokinase during 98 treatments. Place of the biological surveillance (author's transl)].
Topics: Adolescent; Adult; Aged; Arterial Occlusive Diseases; Arteries; Extremities; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Streptokinase | 1979 |
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility | 1977 |
The importance of plasma lipid, glucose, insulin and fibrinogen in femoropopliteal surgery.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Glucose; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Insulin; Lipids; Male; Middle Aged; Popliteal Artery; Recurrence | 1978 |
[Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
Topics: Adult; Ancrod; Arterial Occlusive Diseases; Female; Femoral Artery; Fibrinogen; Humans; Leg; Male; Middle Aged; Popliteal Artery; Thrombophlebitis; Thrombosis | 1978 |
The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease.
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Cholesterol; Female; Fibrinogen; Hematocrit; Humans; Isoxsuprine; Lipids; Male; Middle Aged; Time Factors | 1978 |
[Micro-hemorheology and defibrinogenization. Basis of blood microrheology and active principles of defibrinogenizing therapy].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocyte Aggregation; Fibrinogen; Humans; Microcirculation | 1978 |
Blood rheology in occlusive arterial disease following successful cadaveric kidney transplantation.
Topics: Adult; Arterial Occlusive Diseases; Blood Viscosity; Cadaver; Cholesterol; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Postoperative Complications; Regression Analysis; Transplantation, Homologous; Triglycerides | 1976 |
[Demonstration of arterial vascular occlusions using 125 I-fibrinogen].
Topics: Adult; Aged; Arm; Arterial Occlusive Diseases; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Methods; Middle Aged; Radioisotope Dilution Technique; Thrombophlebitis | 1976 |
[Mode of action and control of "low dose heparin" (author's transl)].
Topics: Arterial Occlusive Diseases; Blood Coagulation Tests; Fibrinogen; Half-Life; Heparin; Humans; Iodine Radioisotopes; Thrombin; Thrombosis | 1977 |
SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusion in man.
Topics: Ancrod; Arterial Occlusive Diseases; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoelectrophoresis; Plasminogen; Streptokinase; Thrombosis | 1977 |
[Diagnosis of thromboembolic diseases].
Topics: Aortic Aneurysm; Arterial Occlusive Diseases; Diagnosis, Differential; Embolism; Erysipelas; Fibrinogen; Humans; Myocardial Infarction; Phlebography; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis; Ultrasonography | 1977 |
Coagulation abnormalities in patients with arterial, venous, and combined arterial and venous thromboses.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Blood Coagulation Disorders; Factor IX; Factor VIII; Factor XI; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Thrombophlebitis; Thrombosis | 1977 |
Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
Topics: Ancrod; Arterial Occlusive Diseases; Blood Circulation; Blood Viscosity; Endopeptidases; Fibrinogen; Humans | 1976 |
Technique and laboratory control of subcutaneously administered defibrase.
Topics: Animals; Antibodies; Arterial Occlusive Diseases; Batroxobin; Fibrinogen; Peptide Hydrolases | 1976 |
[Modified dosage scheme for the subcutaneous use of arvin in patients with chronic arterial occlusive diseases].
Topics: Ancrod; Arterial Occlusive Diseases; Endopeptidases; Fibrinogen; Humans; Injections, Subcutaneous | 1976 |
Intravascular coagulation in surgical procedures on the abdominal aorta.
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Aortic Diseases; Arterial Occlusive Diseases; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Blood Vessel Prosthesis; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prothrombin Time; Thromboplastin | 1976 |
Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Protein Electrophoresis; Densitometry; Electrophoresis, Polyacrylamide Gel; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Molecular Weight; Neoplasms; Surgical Procedures, Operative | 1976 |
Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Topics: Adenosine Triphosphate; Ancrod; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Fibrinogen; Humans; Microcirculation; Osmolar Concentration; Pentoxifylline; Theobromine | 1976 |
[Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Enzymes; Erythrocyte Aggregation; Fibrinogen; Hematocrit; Hemodynamics; Humans; Regional Blood Flow; Rheology; Snake Venoms | 1975 |
Postoperative changes in coagulant and anticoagulant factors following abdominal aortic surgery.
Topics: Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Blood Coagulation Factors; Blood Vessel Prosthesis; Factor V; Factor VIII; Factor X; Female; Fibrinogen; Fibrinolysin; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation; Protein C; Prothrombin Time; Thrombin Time; von Willebrand Factor | 1992 |
Antithrombotic efficacy of low-molecular-weight heparin in deep arterial injury.
Topics: Animals; Arterial Occlusive Diseases; Arteries; Blood Coagulation Tests; Blood Platelets; Fibrinogen; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Swine; Thrombosis | 1992 |
Antithrombin III and arterial disease.
Topics: Antithrombin III; Arterial Occlusive Diseases; Clinical Trials as Topic; Fibrinogen; Research Design | 1992 |
Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis.
Topics: alpha-Macroglobulins; Animals; Arterial Occlusive Diseases; Chiroptera; Dogs; Enzymes; Female; Femoral Artery; Fibrin; Fibrinogen; Fibrinolysin; Male; Plasminogen; Plasminogen Activators; Recurrence; Reperfusion; Salivary Glands; Thrombosis; Tissue Plasminogen Activator | 1992 |
Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study.
Topics: Angiography; Animals; Arterial Occlusive Diseases; Batroxobin; Dogs; Drug Synergism; Female; Fibrinogen; Fibrinolytic Agents; Heparin; Male; Premedication; Serine Endopeptidases; Thrombosis; Tissue Plasminogen Activator | 1989 |
Femoral artery recanalisation with percutaneous angioplasty and segmentally enclosed plasminogen activator.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Catheters, Indwelling; Combined Modality Therapy; Femoral Artery; Fibrinogen; Heparin; Humans; Middle Aged; Plasminogen Activators; Recombinant Proteins; Recurrence; Thrombosis; Time Factors; Vascular Patency | 1989 |
Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
Topics: Aged; Arterial Occlusive Diseases; Blood Platelets; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activators; Thromboembolism; von Willebrand Factor | 1989 |
Hemorheology in systemic ultrahigh-dose thrombolytic therapy with streptokinase and urokinase.
Topics: Adult; Arterial Occlusive Diseases; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Platelet Aggregation; Rheology; Streptokinase; Thrombolytic Therapy; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1989 |
[Cellular rheology in obliterative arterial diseases of the lower limbs].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Leg; Leukocyte Count; Male; Middle Aged | 1989 |
Streptokinase in the management of arterial thrombosis in infancy.
Topics: Arterial Occlusive Diseases; Child, Preschool; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Infant; Infant, Newborn; Male; Pulse; Streptokinase; Thrombosis | 1989 |
Markers of thrombotic activity in arterial disease.
Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Vessel Prosthesis; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Prognosis; Radioimmunoassay; Thrombosis; Time Factors; Wound Healing | 1987 |
Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation.
Topics: Adult; Aged; Arterial Occlusive Diseases; Computers; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Tissue Plasminogen Activator | 1986 |
Pilot study of a screening test for peripheral arterial disease in middle aged men: fibrinogen as a possible risk factor.
Topics: Arterial Occlusive Diseases; Electrocardiography; Exercise Test; Fibrinogen; Humans; Male; Mass Screening; Middle Aged; Pilot Projects; Risk Factors | 1988 |
Hemorheologic parameters in correlation to extracranial carotid artery disease in patients with acute cerebrovascular disorders.
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Carotid Artery Diseases; Carotid Artery, Internal; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Ultrasonography | 1987 |
Low dose intra-arterial streptokinase and acylated plasminogen-streptokinase activator complex: a retrospective review of two thrombolytic regimes in recent peripheral arterial ischaemia.
Topics: Aged; Anistreplase; Arterial Occlusive Diseases; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Leg; Male; Plasminogen; Retrospective Studies; Streptokinase | 1987 |
Reduced fibrinolytic potential in patients with arterial occlusive disease (AOD) in comparison with normal subjects.
Topics: Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Humans; Peptide Fragments; Plasminogen; Reference Values | 1988 |
[Use of fibrin glue in 8 cases of arterial occlusive disease with or without patches].
Topics: Aged; Arterial Occlusive Diseases; Drug Combinations; Evaluation Studies as Topic; Factor XIII; Female; Femoral Artery; Fibrin Tissue Adhesive; Fibrinogen; Humans; Male; Middle Aged; Thrombin; Tissue Adhesives | 1986 |
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
Topics: Aged; Arterial Occlusive Diseases; Blood Coagulation Tests; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; von Willebrand Factor | 1986 |
Effect of defibrinogenation on the early patency rate of experimental small calibre arterial grafts.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Arteries; Blood Coagulation; Blood Vessel Prosthesis; Blood Viscosity; Disease Models, Animal; Fibrinogen; Graft Occlusion, Vascular; Male; Postoperative Complications; Rabbits | 1987 |
Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Theobromine | 1986 |
[Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Fibrinogen; Fibrinolytic Agents; Hemodilution; Humans; Rheology | 1986 |
Studies on haematocrit in peripheral arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Viscosity; Fibrinogen; Hematocrit; Humans; Intermittent Claudication; Male; Middle Aged; Platelet Aggregation; Rheology; Smoking | 1986 |
[Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Ischemia; Leg; Male; Microcirculation; Middle Aged; Rheology | 1986 |
[Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen].
Topics: Acute Disease; Adult; Aged; alpha-2-Antiplasmin; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Injections, Intra-Arterial; Leg; Male; Middle Aged; Peptide Fragments; Plasminogen; Time Factors; Urokinase-Type Plasminogen Activator | 1985 |
[Hemorheologic and blood coagulation studies in 94 patients with chronic obstructive peripheral arterial disease].
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation; Blood Viscosity; Chronic Disease; Erythrocyte Deformability; Factor VIII; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time | 1985 |
Streptokinase as an adjunct to arterial surgery.
Topics: Adult; Aged; Angiography; Arterial Occlusive Diseases; Blood Coagulation Tests; Female; Femoral Artery; Fibrinogen; Fibrinolysin; Humans; Iliac Artery; Infusions, Parenteral; Male; Middle Aged; Popliteal Artery; Pulse; Streptokinase; Thrombosis; Time Factors | 1973 |
Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
Topics: Arterial Occlusive Diseases; Batroxobin; Biological Assay; Blood Coagulation Tests; Chromatography, Agarose; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Molecular Weight; Peptide Hydrolases; Staphylococcus; Thrombin | 1974 |
Peripheral vascular disease today.
Topics: Angiography; Arterial Occlusive Diseases; Arteries; Arteriosclerosis Obliterans; Female; Fibrinogen; Fibrinolytic Agents; Foot Diseases; Heparin; Humans; Intermittent Claudication; Lymphedema; Male; Methods; Plethysmography, Impedance; Thrombosis; Ultrasonography; Vascular Diseases; Venous Insufficiency | 1973 |
[Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
Topics: Animals; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Erythrocytes; Extremities; Fibrinogen; Humans; Peptide Hydrolases; Snakes; Streptokinase; Venoms | 1973 |
New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
Topics: Adult; Aged; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chromium Radioisotopes; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Goats; Heparin; Humans; Male; Microscopy, Phase-Contrast; Middle Aged; Peptide Hydrolases; Snake Venoms; Streptokinase; Thrombophlebitis | 1973 |
The use of laboratory determinations in the control of streptokinase therapy.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation Tests; Densitometry; Female; Fibrinogen; Humans; Male; Middle Aged; Protamines; Prothrombin Time; Streptokinase; Thrombin; Thrombophlebitis; Time Factors | 1972 |
Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
Topics: Administration, Oral; Arterial Occlusive Diseases; Cholesterol; Drug Therapy, Combination; Ethylestrenol; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glass; Humans; Metformin; Methods; Phenformin; Platelet Adhesiveness; Stanozolol; Time Factors | 1972 |
[Research on thrombogenesis in chronic obliterating arteriopathies of the extremities].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Coagulation Disorders; Chronic Disease; Coronary Disease; Extremities; Female; Fibrinogen; Humans; Lipids; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Smoking; Thromboangiitis Obliterans; Thrombosis | 1973 |
Laboratory control of SK therapy.
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Chronic Disease; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Peptide Hydrolases; Plasminogen; Recurrence; Serum Globulins; Snake Venoms; Solubility; Streptokinase; Thrombelastography; Thrombin; Time Factors | 1973 |
[The diagnostic use of I-131-urokinase].
Topics: Arterial Occlusive Diseases; Brachial Artery; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Radioisotopes; Pulmonary Embolism; Radionuclide Imaging; Thigh; Thrombophlebitis | 1974 |
A new approach in the treatment of peripheral arterial occlusions: defibrination with arvin.
Topics: Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Drug Evaluation; Fibrinogen; Fibrinolytic Agents; Hematocrit; Humans; Injections, Intravenous; Leg; Prothrombin Time; Streptodornase and Streptokinase; Venoms | 1974 |